130 related articles for article (PubMed ID: 38295998)
1. Brucea javanica derived exosome-like nanovesicles deliver miRNAs for cancer therapy.
Yan G; Xiao Q; Zhao J; Chen H; Xu Y; Tan M; Peng L
J Control Release; 2024 Mar; 367():425-440. PubMed ID: 38295998
[TBL] [Abstract][Full Text] [Related]
2. Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppressive Microenvironment.
Zhang Z; Luo X; Xue X; Pang M; Wang X; Yu L; Qian J; Li X; Tian M; Lu A; Lu C; Liu Y
Int J Nanomedicine; 2024; 19():743-758. PubMed ID: 38283199
[TBL] [Abstract][Full Text] [Related]
3. Ethanol Extract of
Chen X; Li S; Li D; Li M; Su Z; Lai X; Zhou C; Chen S; Li S; Yang X; Su J; Zhang Y
Front Pharmacol; 2020; 11():606. PubMed ID: 32411003
[TBL] [Abstract][Full Text] [Related]
4. Exosomes derived from stem cells of human deciduous exfoliated teeth inhibit angiogenesis in vivo and in vitro via the transfer of miR-100-5p and miR-1246.
Liu P; Zhang Q; Mi J; Wang S; Xu Q; Zhuang D; Chen W; Liu C; Zhang L; Guo J; Wu X
Stem Cell Res Ther; 2022 Mar; 13(1):89. PubMed ID: 35241153
[TBL] [Abstract][Full Text] [Related]
5. Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer.
Li C; Yoshimura T; Tian M; Wang Y; Kondo T; Yamamoto KI; Fujisawa M; Ohara T; Sakaguchi M; Matsukawa A
Breast Cancer Res; 2022 Sep; 24(1):60. PubMed ID: 36096830
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
7. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
[TBL] [Abstract][Full Text] [Related]
9. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
10. Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness.
De P; Sun Y; Carlson JH; Friedman LS; Leyland-Jones BR; Dey N
Neoplasia; 2014 Jan; 16(1):43-72. PubMed ID: 24563619
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway.
Wang LL; Huang WW; Huang J; Huang RF; Li NN; Hong Y; Chen ML; Wu F; Liu J
Kaohsiung J Med Sci; 2020 Aug; 36(8):581-591. PubMed ID: 32311203
[TBL] [Abstract][Full Text] [Related]
12. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells.
Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644
[TBL] [Abstract][Full Text] [Related]
13. Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway.
Yu M; Liu W; Li J; Lu J; Lu H; Jia W; Liu F
Stem Cell Res Ther; 2020 Aug; 11(1):350. PubMed ID: 32787917
[TBL] [Abstract][Full Text] [Related]
14. Exosome-Encapsulated microRNA-140-5p Alleviates Neuronal Injury Following Subarachnoid Hemorrhage by Regulating IGFBP5-Mediated PI3K/AKT Signaling Pathway.
Wang P; Xue Y; Zuo Y; Xue Y; Zhang JH; Duan J; Liu F; Liu A
Mol Neurobiol; 2022 Dec; 59(12):7212-7228. PubMed ID: 36129637
[TBL] [Abstract][Full Text] [Related]
15. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway.
Wei S; Zhang Y; Ma X; Yao Y; Zhou Q; Zhang W; Zhou C; Zhuang J
Sci Rep; 2023 Jul; 13(1):12351. PubMed ID: 37524857
[TBL] [Abstract][Full Text] [Related]
16. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
17. Exosomes from umbilical cord-derived mesenchymal stem cells combined with gelatin methacryloyl inhibit vein graft restenosis by enhancing endothelial functions.
Deng Y; Li Y; Chu Z; Dai C; Ge J
J Nanobiotechnology; 2023 Oct; 21(1):380. PubMed ID: 37848990
[TBL] [Abstract][Full Text] [Related]
18. In Vitro and In Vivo Anti-Cancer Activity of Lasiokaurin in a Triple-Negative Breast Cancer Model.
Lin J; Qu Z; Pu H; Shen LS; Yi X; Lin YS; Gong RH; Chen GQ; Chen S
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067432
[TBL] [Abstract][Full Text] [Related]
19. Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis.
Yang SJ; Wang DD; Zhong SL; Chen WQ; Wang FL; Zhang J; Xu WX; Xu D; Zhang Q; Li J; Zhang HD; Hou JC; Mao L; Tang JH
Cell Death Dis; 2021 Apr; 12(5):420. PubMed ID: 33911067
[TBL] [Abstract][Full Text] [Related]
20. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.
Wu C; Qiu S; Liu P; Ge Y; Gao X
J Ethnopharmacol; 2018 Jan; 211():89-100. PubMed ID: 28962890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
